Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sung Joon Hong

Showing results (1-10 of 156) with videos related to

Pageof 16
Sort By:
BJU International|December 13, 2005
Long-term follow-up study to evaluate the efficacy and safety of the doxazosin gastrointestinal therapeutic system in patients with benign prostatic hyperplasia with or without concomitant hypertensionByung Ha Chung, Sung Joon Hong
Journal of Cancer Research and Clinical Oncology|May 27, 2014
Serum alkaline phosphatase differentiates prostate-specific antigen flare from early disease progression after docetaxel chemotherapy in castration-resistant prostate cancer with bone metastasisKyung Seok Han, Sung Joon Hong
Yonsei Medical Journal|February 17, 2015
Exponential rise in prostate-specific antigen (PSA) during anti-androgen withdrawal predicts PSA flare after docetaxel chemotherapy in patients with castration-resistant prostate cancerKyung Seok Han, Sung Joon Hong
Materials (Basel, Switzerland)|June 19, 2024
Taguchi Optimization of Wetting, Thermal and Mechanical Properties of Sn-1.0wt.%Ag-0.5wt.%Cu Alloys Modified with Bi and SbSung-Joon Hong, Ashutosh Sharma, Jae Pil Jung
BMC Cancer|October 29, 2015
Predicting the response of patients with advanced urothelial cancer to methotrexate, vinblastine, Adriamycin, and cisplatin (MVAC) after the failure of gemcitabine and platinum (GP)Ki Hong Kim, Sung Joon Hong, Kyung Seok Han
International Journal of Urology : Official Journal of the Japanese Urological Association|March 1, 2005
Doxazosin for benign prostatic hyperplasia: an open-label, baseline-controlled study in Korean general practiceByung Ha Chung, Sung Joon Hong, Moo Sang Lee
Nutrition and Cancer|November 22, 2011
Inhibition of IGF-1 signaling by genistein: modulation of E-cadherin expression and downregulation of β-catenin signaling in hormone refractory PC-3 prostate cancer cellsJoomin Lee, Jihyeung Ju, Seyeon Park, et al.
European Urology|June 20, 2003
Identification of baseline clinical factors which predict medical treatment failure of benign prostatic hyperplasia: an observational cohort studySung Joon Hong, Woo Jin Ko, Sun Il Kim, et al.
BJU International|March 16, 2006
Relationship between serum prostate-specific antigen and prostate volume in Korean men with benign prostatic hyperplasia: a multicentre studyByung Ha Chung, Sung Joon Hong, Jin Seon Cho, et al.
Urology|November 10, 2007
Grade of hydronephrosis and tumor diameter as preoperative prognostic factors in ureteral transitional cell carcinomaKang Su Cho, Sung Joon Hong, Nam Hoon Cho, et al.
Pageof 16

Showing results (1-10 of 156) with videos related to

Sort By:
Pageof 16
BJU International|December 13, 2005
Long-term follow-up study to evaluate the efficacy and safety of the doxazosin gastrointestinal therapeutic system in patients with benign prostatic hyperplasia with or without concomitant hypertensionByung Ha Chung, Sung Joon Hong
Journal of Cancer Research and Clinical Oncology|May 27, 2014
Serum alkaline phosphatase differentiates prostate-specific antigen flare from early disease progression after docetaxel chemotherapy in castration-resistant prostate cancer with bone metastasisKyung Seok Han, Sung Joon Hong
Yonsei Medical Journal|February 17, 2015
Exponential rise in prostate-specific antigen (PSA) during anti-androgen withdrawal predicts PSA flare after docetaxel chemotherapy in patients with castration-resistant prostate cancerKyung Seok Han, Sung Joon Hong
Materials (Basel, Switzerland)|June 19, 2024
Taguchi Optimization of Wetting, Thermal and Mechanical Properties of Sn-1.0wt.%Ag-0.5wt.%Cu Alloys Modified with Bi and SbSung-Joon Hong, Ashutosh Sharma, Jae Pil Jung
BMC Cancer|October 29, 2015
Predicting the response of patients with advanced urothelial cancer to methotrexate, vinblastine, Adriamycin, and cisplatin (MVAC) after the failure of gemcitabine and platinum (GP)Ki Hong Kim, Sung Joon Hong, Kyung Seok Han
International Journal of Urology : Official Journal of the Japanese Urological Association|March 1, 2005
Doxazosin for benign prostatic hyperplasia: an open-label, baseline-controlled study in Korean general practiceByung Ha Chung, Sung Joon Hong, Moo Sang Lee
Nutrition and Cancer|November 22, 2011
Inhibition of IGF-1 signaling by genistein: modulation of E-cadherin expression and downregulation of β-catenin signaling in hormone refractory PC-3 prostate cancer cellsJoomin Lee, Jihyeung Ju, Seyeon Park, et al.
European Urology|June 20, 2003
Identification of baseline clinical factors which predict medical treatment failure of benign prostatic hyperplasia: an observational cohort studySung Joon Hong, Woo Jin Ko, Sun Il Kim, et al.
BJU International|March 16, 2006
Relationship between serum prostate-specific antigen and prostate volume in Korean men with benign prostatic hyperplasia: a multicentre studyByung Ha Chung, Sung Joon Hong, Jin Seon Cho, et al.
Urology|November 10, 2007
Grade of hydronephrosis and tumor diameter as preoperative prognostic factors in ureteral transitional cell carcinomaKang Su Cho, Sung Joon Hong, Nam Hoon Cho, et al.
Pageof 16